Lucida Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Aurangabad, Maharashtra, India, established in 2018.
2018 Aurangabad, Maharashtra, India Active
Last Updated:
Access Report
About Lucida Pharmaceuticals Private Limited

Lucida Pharmaceuticals Private Limited, a active private limited company, was established on 03 April 2018 in Aurangabad, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U52609MH2018PTC307410. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Deepali Rajendra Kalantri (Director), Mahesh Rameshwar Kalantri (Director). Past directors included Nisharani Nileshkumar Agrawal. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 16 Shreya Nagar Near Kalda Corner, Aurangabad, Maharashtra, 431005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U52609MH2018PTC307410

  • Registration Number

    307410

  • Incorporation Date

    03 April 2018

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 83.94%
  • Profit Growth **** 99.78%
  • Ebitda **** 115.68%
  • Net Worth -0.25%
  • Total Assets **** 18.72%
Company report

Lucida Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lucida Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Lucida Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepali Rajendra Kalantri Director 06 Jun 2018 Current
Mahesh Rameshwar Kalantri Director 03 Apr 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Jun 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lucida Pharmaceuticals.

Lucida Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 83.94% increase. The company also saw a substantial improvement in profitability, with a 99.78% increase in profit. The company's net worth dipped by a decrease of 0.25%.

Lucida Pharmaceuticals revenue growth over time
Lucida Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 83.94%
*******
*******
*******
*******
Revenue from Operations
*******
 83.94%
*******
*******
*******
*******
Total Assets
*******
 18.72%
*******
*******
*******
*******
Profit or Loss
*******
 99.78%
*******
*******
*******
*******
Net Worth
*******
 -0.25%
*******
*******
*******
*******
EBITDA
*******
 115.68%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lucida Pharmaceuticals?

In 2019, Lucida Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lucida Pharmaceuticals?

Unlock and access historical data on people associated with Lucida Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lucida Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lucida Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lucida Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Lucida Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Lucida Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    Deepali Rajendra Kalantri was appointed as a Director was appointed as a Director on 06 Jun 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.

  • Director Appointment

    The activity Mahesh Rameshwar Kalantri was appointed as a Director was appointed as a Director on 03 Apr 2018 & has been associated with this company since 7 years 10 months . was completed.

  • Company Incorporation

    Progress on Lucida Pharmaceuticals Private Limited was registered on 03 Apr 2018 with Roc Mumbai & aged 7 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lucida Pharmaceuticals Private Limited?

The CIN of Lucida Pharmaceuticals Private Limited is U52609MH2018PTC307410.

Where is Lucida Pharmaceuticals Private Limited headquartered?

Lucida Pharmaceuticals Private Limited is headquartered at Plot No 16 Shreya Nagar Near Kalda Corner, Aurangabad, Maharashtra, 431005.

When was Lucida Pharmaceuticals Private Limited incorporated?

Lucida Pharmaceuticals Private Limited was incorporated on 03 April 2018.

Who are the current directors of Lucida Pharmaceuticals Private Limited?

The current directors of Lucida Pharmaceuticals Private Limited are

What is the primary industry of Lucida Pharmaceuticals Private Limited?

The primary industry of Lucida Pharmaceuticals Private Limited is Pharma.

Is Lucida Pharmaceuticals Private Limited a listed company?

Lucida Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Lucida Pharmaceuticals Private Limited?

The authorized capital of Lucida Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available